Literature DB >> 9607375

Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy.

M J Roman1, M H Alderman, T G Pickering, R Pini, J O Keating, J E Sealey, R B Devereux.   

Abstract

Diuretic-based therapy is less effective in reducing the cardiac complications of hypertension than the risk of stroke and may be less effective in reducing left ventricular (LV) mass than is therapy with angiotensin converting enzyme (ACE) inhibition. In view of the strong association of LV hypertrophy with cardiovascular risk, this study was designed to compare the impact of therapy with a diuretic and ACE inhibition on cardiac and vascular structure. Fifty essential hypertensives (74% male, 88% nonwhite) participated in a double-blind study for 6 months and were randomized to either ramipril or hydrochlorothiazide (HCTZ). Echocardiography, carotid ultrasonography, and ambulatory blood pressure (BP) monitoring were performed at baseline and 3 and 6 months after initiation of therapy. The 22 ramipril patients were comparable to the 28 HCTZ patients at baseline in age, race, and 24-h BP. Although HCTZ resulted in a greater reduction in 24-h BP, only treatment with ramipril resulted in a decrease in LV mass (193 to 179 g, P < .005, v 184 to 182 g, P = NS), attributable to a reduction in wall thicknesses but not in chamber diameter. In multivariate analysis, both change in BP and treatment group were independent predictors of change in LV mass. Importantly, although neither drug reduced carotid artery cross-sectional area, relative wall thickness increased due to a tendency for vessel diameter to decrease and wall thickness to increase, particularly in the diuretic group. Ramipril caused a sustained fall in plasma angiotensin II, whereas HCTZ increased angiotensin II levels. Although diuretic therapy was more effective in lowering ambulatory BP in this predominantly nonwhite population, only therapy with ACE inhibition was associated with regression of LV mass. Vascular geometry was altered consistent with the reduction in distending pressure resulting in vascular remodelling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607375     DOI: 10.1016/s0895-7061(97)00492-5

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  19 in total

Review 1.  Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States?

Authors:  Ralph G Hawkins
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

2.  Noninvasive assessment of vascular structure and function in conscious rats based on in vivo imaging of the albino iris.

Authors:  Harald M Stauss; Kevin R Rarick; Katie M Leick; Jason W Burkle; Diane L Rotella; Michael G Anderson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-03-09       Impact factor: 3.619

3.  Reversal of experimental renovascular hypertension restores coronary microvascular function and architecture.

Authors:  Victor H Urbieta-Caceres; Xiang-Yang Zhu; Matthew E Gibson; Frederic D Favreau; Kyra Jordan; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2011-01-13       Impact factor: 2.689

Review 4.  Kidney aging--inevitable or preventable?

Authors:  Devasmita Choudhury; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

Review 5.  Antihypertensive Therapies and Left Ventricular Hypertrophy.

Authors:  Elsayed Z Soliman; Ronald J Prineas
Journal:  Curr Hypertens Rep       Date:  2017-09-19       Impact factor: 5.369

Review 6.  Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.

Authors:  Ezequiel Balmori Melian; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Authors:  Elsayed Z Soliman; Walter T Ambrosius; William C Cushman; Zhu-Ming Zhang; Jeffrey T Bates; Javier A Neyra; Thaddeus Y Carson; Leonardo Tamariz; Lama Ghazi; Monique E Cho; Brian P Shapiro; Jiang He; Lawrence J Fine; Cora E Lewis
Journal:  Circulation       Date:  2017-05-16       Impact factor: 29.690

Review 8.  Hypertension and concomitant diseases: a guide for evidence-based therapy.

Authors:  Tamrat M Retta; Otelio S Randall
Journal:  J Natl Med Assoc       Date:  2004-04       Impact factor: 1.798

Review 9.  Thiazide Diuretic-Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials.

Authors:  Jill J Hall; Dean T Eurich; Danielle Nagy; Lisa Tjosvold; John-Michael Gamble
Journal:  J Gen Intern Med       Date:  2020-03-10       Impact factor: 5.128

10.  Change in cardiac geometry and function in CKD children during strict BP control: a randomized study.

Authors:  Maria Chiara Matteucci; Marcello Chinali; Gabriele Rinelli; Elke Wühl; Aleksandra Zurowska; Marina Charbit; Giacomo Pongiglione; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-02       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.